Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.

MLA

Zweijpfenning, Sanne M. H., et al. “Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium Avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.” Chest, vol. 165, no. 5, May 2024, pp. 1082–92. EBSCOhost, https://doi.org/10.1016/j.chest.2023.11.038.

APA

Zweijpfenning, S. M. H., Aarnoutse, R., Boeree, M. J., Magis-Escurra, C., Stemkens, R., Geurts, B., van Ingen, J., & Hoefsloot, W. (2024). Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial. Chest, 165(5), 1082–1092. https://doi.org/10.1016/j.chest.2023.11.038

Chicago

Zweijpfenning, Sanne M H, Rob Aarnoutse, Martin J Boeree, Cecile Magis-Escurra, Ralf Stemkens, Bram Geurts, Jakko van Ingen, and Wouter Hoefsloot. 2024. “Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium Avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.” Chest 165 (5): 1082–92. doi:10.1016/j.chest.2023.11.038.